logo
Restaurants could run out of cheese after UK bans European cheese imports

Restaurants could run out of cheese after UK bans European cheese imports

Metro15-07-2025
Fans of some of the most popular cheeses made in Italy and France could be left disappointed after imports to the UK were banned.
There's been an outbreak of lumpy skin disease (LSD) in both European countries, which means the UK government has banned certain types of cheese from being imported.
Cases of the viral disease have been reported on the Italian island of Sardinia as well as in south east France in recent weeks.
To try and prevent the disease spreading to the UK, the Department for Environment, Food and Rural Affairs (Defra) has halted the importation of unpasteurised dairy products produced any time after May 23.
While pasteurised cheeses such as pecorino romano from Italy can still make it into the UK (as long as the cheese's treatment processes are up to scratch), some of the most popular unpasteurised cheeses are currently banned.
Upmarket cheesemongers say this has caused their supplies of products like mozzarella, fresh goat's cheese and brie to run low – and the situation will continue to worsen as new products are slow to arrive.
Patricia Michelson, founder of artisan cheese distributor La Fromagerie based in Marylebone, said she is losing thousands of pounds worth of stock which is spoiling at the border.
She told The Times: 'Every week our lorries are getting delayed. Even though they're chilled, it's not in the right environment and things come in and have to be binned.
Lumpy skin disease (LSD) is a viral disease which causes fever and reduced milk production in cows and water buffalo.
The disease causes the cattle to develop skin nodules and lesions, as well as producing discharge from the eyes and nose.
Cattle catch the disease through insect bites, but while humans cannot be affected by LSD, it's a notifiable disease because of its potential impact on animal health.
The disease was first found in Zambia in the 1920s, and since then it has spread across Africa, with Morocco the only African country to have never recorded cases of it.
In the mid-2010s the illness entered mainland Europe through Greece, the Balkans and Russia.
'We can't charge the producer, it's not their fault, they sent it all in perfect condition, it's what happens when it's stuck at the port.
'At the moment, we can't supply all the lovely, soft cow's milk cheeses like Camembert and brie.
'If people think that they can get what they want now, they won't, because everywhere will be slowly running out of stock.
'From Monday we will only be able to offer an English brie-style cheese.'
La Fromagerie supplies more than 100 restaurants, including Gordon Ramsay's restaurant in Chelsea and triple Michelin starred Core. More Trending
But Patricia says it has just sent out the last of its stock of French brie, and supplies of other fine cheese are in a 'precarious position'.
A Defra spokesperson said: 'This government will do whatever it takes to protect British farmers and their herds from disease.
'We have strengthened protections by temporarily suspending imports of a small amount of products from Italy and France, following outbreaks of lumpy skin disease across Europe.
'Unpasteurised cheeses are restricted, but as most Italian cheeses, such as parmesan, mozzarella, and gorgonzola, are pasteurised this should not have a significant impact on supply chains.'
Get in touch with our news team by emailing us at webnews@metro.co.uk.
For more stories like this, check our news page.
MORE: Huge changes to mortgages for first-time buyers set to be unveiled today
MORE: You could be given £3,750 off electric cars under new government grant scheme
MORE: Mother of British hiker Matthew Hall, 33, missing in Alps tells of nightmare
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Coca-Cola will launch version with U.S. cane sugar after Trump push
Coca-Cola will launch version with U.S. cane sugar after Trump push

NBC News

time43 minutes ago

  • NBC News

Coca-Cola will launch version with U.S. cane sugar after Trump push

The Coca-Cola Company said Tuesday that it will launch a version of its signature drink made with U.S. cane sugar. The announcement comes days after President Donald Trump posted on Truth Social that he had "been speaking to Coca-Cola about using REAL Cane Sugar in Coke in the United States, and they have agreed to do so." Initially, Coca-Cola did not confirm the news. The company told NBC News last week that it appreciated Trump's "enthusiasm for our iconic Coca-Cola brand" but that " be shared soon." The company said in its earnings release Tuesday morning that a version of the drink with cane sugar was indeed coming later this year. "As part of its ongoing innovation agenda, this fall in the United States, the company plans to launch an offering made with U.S. cane sugar to expand its Trademark Coca-Cola product range," its news release said. Coca-Cola produced for the U.S. market is typically sweetened with corn syrup, while the company uses cane sugar in some other countries, including Mexico and various European countries. In the United States, Coca-Cola made with cane sugar is colloquially known as "Mexican Coke." The Coke made with U.S. cane sugar will complement the company's existing product line, the company added. Last wee,k Trump said "this will be a very good move by them — You'll see. It's just better!" The Trump administration's Make America Healthy Again initiative, named for the social movement aligned with Health Secretary Robert F. Kennedy Jr., has pushed food companies to alter their formulations to remove ingredients like artificial dyes. While taste preferences may differ, the health impact of cane sugar and high fructose corn syrup is essentially the same. Dr. Dariush Mozaffarian, a cardiologist and director of the Food is Medicine Institute at the Friedman School of Nutrition Science and Policy at Tufts University, said that 'both high-fructose corn syrup and cane sugar are about 50% fructose, 50% glucose, and have identical metabolic effects." That is, both can equally raise the risk for obesity, diabetes, and high triglycerides and blood pressure. Both provide the same number of calories, but the body processes them differently.

Two serious illnesses 'being spread' in favourite UK holiday destination
Two serious illnesses 'being spread' in favourite UK holiday destination

Daily Mirror

timea day ago

  • Daily Mirror

Two serious illnesses 'being spread' in favourite UK holiday destination

Tourists have been given a warning after it emerged two serious illnesses are being transmitted in a favourite holiday destination. British holidaymakers have been issued a health alert regarding two serious diseases found in a popular travel destination. The Foreign Office-supported Travel Health Pro website has disclosed that Dengue and Chikungunya have both been detected in Italy. ‌ These illnesses have been identified previously, but all instances were contracted abroad. However, Italian health officials have now reported two new cases diagnosed in individuals who contracted the diseases within the country, raising fears of local transmission. ‌ In relation to Dengue, as of 15 July 2025, the Italian health authorities announced the first locally acquired case of the year. This case was reported in the Emilia Romagna region. ‌ Additionally, 82 imported cases of the disease have been documented across various regions. Similarly, by the same date, health officials also reported the first locally acquired case of Chikungunya for the year. This case was again identified in the Emilia Romagna region. A further 50 imported cases of the disease have been recorded in several regions. ‌ Chikungunya Chikungunya is a viral infection caused by the chikungunya virus (CHIKV), an alphavirus spread through mosquito bites. The mosquitoes that carry chikungunya are active from sunrise to sunset, particularly at dawn and dusk. They breed in natural and man-made containers such as flowerpots and old tyres, which pose a risk factor for transmission if left near human dwellings. Chikungunya, while uncomfortable, is seldom life-threatening. Symptoms typically manifest 4-8 days post an infected mosquito bite and include:. ‌ In rare instances, individuals may contract the CHIKV virus without exhibiting any symptoms. While symptoms generally subside within 1–2 weeks, severe joint pain can linger for months or even years. Sporadic reports of complications involving the eyes, nervous system, heart, and digestive system have been noted. There's no specific antiviral treatment for chikungunya. The recommended course of action includes rest, hydration, and over-the-counter pain and fever relievers like ibuprofen or paracetamol. ‌ Dengue Dengue is an infectious disease caused by four distinct types (serogroups) of the dengue virus: DENV-1, DENV-2, DENV-3, and DENV-4. The disease is transmitted through the bite of an infected mosquito. These mosquitoes typically breed in urban areas near human dwellings and are most active during daylight hours. Although unpleasant, dengue is usually a self-limiting illness. However, a small yet significant number of people can develop a more serious infection (severe dengue). Travel health pro has issued a statement saying: "Approximately 40 to 80 per cent of people infected with dengue remain symptom-free. If symptoms do occur, the illness usually begins abruptly with a high fever, and is often accompanied by a severe headache, muscle and joint pain, nausea, vomiting and a rash. Most infections are self-limiting, with a rapid recovery three to four days after the rash appears." They also warned: "A small number of people develop more severe illness with symptoms which can include dangerously low blood pressure (shock), fluid build-up in the lungs and severe bleeding. There is no specific drug treatment for severe dengue illness, although hospital admission and careful management of fever, fluid balance and pain can help with recovery. If left untreated, severe dengue illness can be fatal. With good medical care, death due to severe dengue is typically less than one per cent."

A genetic test could predict the odds of obesity, allowing for early interventions
A genetic test could predict the odds of obesity, allowing for early interventions

NBC News

timea day ago

  • NBC News

A genetic test could predict the odds of obesity, allowing for early interventions

A genetic test may one day predict a child's risk of obesity in adulthood, paving the way for early interventions. Certain genetic variants can affect how a person's body stores fat or make them more prone to overeating. Genetic variation can also predict how well a person will respond to different weight loss drugs. In a study published Monday in the journal Nature Medicine, more than 600 researchers from around the world worked together to compile genetic data from more than 5 million people — the largest and most diverse genetic dataset to date. They also used genetic data from 23andMe. From the dataset, the researchers were able to create what's known as a polygenic risk score, which takes into account which genetic variants a person has that have been linked to a higher BMI in adulthood. The score, the researchers said, could be used to predict a person's risk of obesity as an adult — before they even turn 5. 'Childhood is the best time to intervene,' said study co-author Ruth Loos, a professor at the University of Copenhagen's Novo Nordisk Foundation Center for Basic Metabolic Research. (Research conducted at the center is not influenced by drugmaker Novo Nordisk, though some of the study authors had ties to pharmaceutical companies that make weight loss drugs.) The findings come as obesity is rising around the world. Rates of obesity in adults have more than doubled globally since 1990, and adolescent rates have quadrupled, according to the World Health Organization. About 16% of adults worldwide have obesity and the situation is worse in the United States, where more than 40% of adults have obesity, Centers for Disease Control and Prevention statistics show. Twice as effective The new test is not the first that predicts a person's risk of obesity, but Loos and her team showed it was about twice as effective as the method doctors currently use to assess their patients. That polygenetic score can account for about 8.5% of a person's risk for having a high BMI as an adult. The new score increased that to about 17.6%, at least in people with European ancestry. 'That's a pretty powerful risk indicator for obesity, but it still leaves open a lot that is unknown,' said Dr. Roy Kim, a pediatric endocrinologist at Cleveland Clinic Children's who was not involved with the research. Based on this score, more than 80% of a person's risk for obesity can be explained by other factors, such as where they live, what kinds of foods they have access to, and how much they exercise. The test was not nearly as effective in predicting obesity risk in non-Europeans. It explained about 16% of the risk for having a high BMI in East Asian Americans, but just 2.2% in rural Ugandans. About 70% of people whose data was included in the study were of predominantly European ancestry. About 14% were Hispanic and typically had a mix of ancestries. About 8% were of predominantly East Asian descent and just under 5% were of predominantly African ancestry. These samples were predominantly from African American people, who largely had mixed ancestry. Just 1.5% were of predominantly South Asian ancestry. Loos said the new score is a big step forward, but that it's still a prototype. The next step is to collect more — and more diverse — data on people with African ancestry in particular to improve how well the score works for everyone, not just white people. She said the score could offer one indicator — what high blood pressure is to heart disease, for example — that could help predict a person's risk of developing obesity. 'Obesity is not only about genetics, so genetics alone can never accurately predict obesity,' Loos said. 'For the general obesity that we see all over the world, we need other factors such as lifestyle that need to be part of the predictions.' Genetics play a bigger role in severe obesity, meaning a BMI of more than 40, she added. Still, identifying a person's genetic risk early on in childhood and intervening early with lifestyle coaching could make a big difference, she said. Research has shown that about 55% of children with obesity go on to have obesity in adolescence, and that about 80% of those individuals will have obesity in adulthood. 'Behavioral things are really important,' Kim said. 'Their environment, their access to healthy food, exercise opportunities, even their knowledge about healthy foods all affect a person's obesity risk.' How important are genetics, really? Although studies in identical twins have found that genetics can account for as much as 80% of the reason a person has obesity, lifestyle factors still play a huge role, Kim said. 'Even with the same genetic makeup, people can have different body types,' he said. 'From a very young age in my practice, we educate patients about the importance of eating protein-rich foods, a lot of fruits and vegetables and not too many refined carbs.' Dr. Juliana Simonetti, co-director of the Comprehensive Weight Management Program at the University of Utah, has been using genetic testing in her adult patients for about five years. She said understanding a person's genes can help doctors better treat weight gain. 'Obesity is not homogeneous. We have different kinds and different presentations,' said Simonetti, who wasn't involved with the new study. Simonetti uses a person's genes to determine if a patient struggles with satiety, or feeling full. 'They eat but do not feel full,' Simonetti said, adding that this is a disorder caused by genetic mutations affecting certain pathways in the body. People who have these mutations 'tend to have higher weight,' she said. But such mutations do not tell the whole genetic story of obesity, Simonetti said. The genes that a person inherits from either parent, even if they are not mutations, also determine how a person's body stores weight or uses energy. Both can play a big role in obesity risk. Genetic testing is also starting to be able to determine how well certain weight loss drugs will work for a person, Simonetti said, but she added this is just the beginning. 'We are talking about three out of 80 mutations that we can treat,' she said. 'We are getting better, and the more data we have, I'm hopeful that we are going to do a better job in being more precise in understanding treatment responses.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store